Axa S.A. Purchases 100,856 Shares of Globe Life Inc. (NYSE:GL)

Axa S.A. increased its position in Globe Life Inc. (NYSE:GL - Free Report) by 205.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 150,040 shares of the company's stock after acquiring an additional 100,856 shares during the quarter. Axa S.A. owned about 0.18% of Globe Life worth $16,732,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of GL. Versant Capital Management Inc increased its stake in shares of Globe Life by 388.0% in the fourth quarter. Versant Capital Management Inc now owns 244 shares of the company's stock worth $27,000 after purchasing an additional 194 shares during the period. Rakuten Securities Inc. acquired a new stake in Globe Life in the 4th quarter valued at approximately $28,000. Albion Financial Group UT bought a new position in Globe Life in the 4th quarter worth approximately $28,000. Avalon Trust Co acquired a new position in shares of Globe Life during the fourth quarter worth approximately $41,000. Finally, EverSource Wealth Advisors LLC boosted its position in shares of Globe Life by 32.7% in the fourth quarter. EverSource Wealth Advisors LLC now owns 365 shares of the company's stock valued at $41,000 after acquiring an additional 90 shares during the period. Institutional investors and hedge funds own 81.61% of the company's stock.

Insider Activity

In other Globe Life news, CEO James Matthew Darden sold 24,890 shares of the company's stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $121.52, for a total transaction of $3,024,632.80. Following the transaction, the chief executive officer now owns 38,973 shares of the company's stock, valued at approximately $4,735,998.96. This represents a 38.97 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Frank M. Svoboda sold 11,000 shares of the stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $122.31, for a total value of $1,345,410.00. Following the completion of the transaction, the chief executive officer now owns 18,948 shares in the company, valued at $2,317,529.88. The trade was a 36.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.51% of the stock is currently owned by corporate insiders.

Globe Life Stock Up 3.4 %

GL opened at $121.78 on Monday. The firm has a market cap of $10.14 billion, a price-to-earnings ratio of 10.19 and a beta of 0.56. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.05 and a current ratio of 0.05. The firm's 50-day simple moving average is $124.02 and its 200-day simple moving average is $116.84. Globe Life Inc. has a twelve month low of $76.55 and a twelve month high of $133.76.

Globe Life (NYSE:GL - Get Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The company reported $3.07 earnings per share for the quarter, missing the consensus estimate of $3.24 by ($0.17). The firm had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.49 billion. Globe Life had a return on equity of 22.32% and a net margin of 18.53%. The business's quarterly revenue was up 4.5% on a year-over-year basis. During the same period in the previous year, the business posted $2.78 EPS. Equities research analysts anticipate that Globe Life Inc. will post 13.87 EPS for the current fiscal year.

Globe Life Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 1st. Stockholders of record on Thursday, July 3rd will be issued a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.89%. The ex-dividend date of this dividend is Thursday, July 3rd. Globe Life's payout ratio is presently 8.79%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on GL. Wells Fargo & Company cut their target price on shares of Globe Life from $141.00 to $140.00 and set an "overweight" rating for the company in a research note on Thursday, April 10th. Piper Sandler cut their price objective on shares of Globe Life from $152.00 to $147.00 and set an "overweight" rating for the company in a research report on Friday. JPMorgan Chase & Co. lifted their target price on Globe Life from $136.00 to $145.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 2nd. Keefe, Bruyette & Woods raised their price objective on Globe Life from $137.00 to $145.00 and gave the stock an "outperform" rating in a research report on Wednesday, February 12th. Finally, Morgan Stanley lowered their price objective on Globe Life from $126.00 to $117.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 10th. Four investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Globe Life currently has a consensus rating of "Moderate Buy" and a consensus target price of $137.09.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.